Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 48 entries
Sorted by: Best Match Show Resources per page
Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteria.

RSC medicinal chemistry

Naclerio GA, Abutaleb NS, Onyedibe KI, Seleem MN, Sintim HO.
PMID: 33479609
RSC Med Chem. 2019 Dec 16;11(1):102-110. doi: 10.1039/c9md00391f. eCollection 2020 Jan 01.

According to the Centers for Disease Control and Prevention (CDC), methicillin-resistant

Cite
Naclerio GA, Abutaleb NS, Onyedibe KI, et al. Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteria. RSC Med Chem. 2019;11(1):102-110doi: 10.1039/c9md00391f.
Naclerio, G. A., Abutaleb, N. S., Onyedibe, K. I., Seleem, M. N., & Sintim, H. O. (2020). Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteria. RSC medicinal chemistry, 11(1), 102-110. https://doi.org/10.1039/c9md00391f
Naclerio, George A, et al. "Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteria." RSC medicinal chemistry vol. 11,1 (2020): 102-110. doi: https://doi.org/10.1039/c9md00391f
Naclerio GA, Abutaleb NS, Onyedibe KI, Seleem MN, Sintim HO. Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteria. RSC Med Chem. 2019 Dec 16;11(1):102-110. doi: 10.1039/c9md00391f. eCollection 2020 Jan 01. PMID: 33479609; PMCID: PMC7536820.
Copy Download .nbib Format: NLM
Surface Electromyography Analysis of Three Squat Exercises.

Journal of human kinetics

Monajati A, Larumbe-Zabala E, Goss-Sampson M, Naclerio F.
PMID: 31523307
J Hum Kinet. 2019 Jul 05;67:73-83. doi: 10.2478/hukin-2018-0073. eCollection 2019 Jun.

The aim of this study was to perform an electromyography comparison of three commonly used lower limb injury prevention exercises: a single-leg squat on a bench (SLSB), a double-leg squat (DLS) and a double-leg squat on a BOSU® balance...

Cite
Monajati A, Larumbe-Zabala E, Goss-Sampson M, et al. Surface Electromyography Analysis of Three Squat Exercises. J Hum Kinet. 2019;67:73-83doi: 10.2478/hukin-2018-0073.
Monajati, A., Larumbe-Zabala, E., Goss-Sampson, M., & Naclerio, F. (2019). Surface Electromyography Analysis of Three Squat Exercises. Journal of human kinetics, 6773-83. https://doi.org/10.2478/hukin-2018-0073
Monajati, Alireza, et al. "Surface Electromyography Analysis of Three Squat Exercises." Journal of human kinetics vol. 67 (2019): 73-83. doi: https://doi.org/10.2478/hukin-2018-0073
Monajati A, Larumbe-Zabala E, Goss-Sampson M, Naclerio F. Surface Electromyography Analysis of Three Squat Exercises. J Hum Kinet. 2019 Jul 05;67:73-83. doi: 10.2478/hukin-2018-0073. eCollection 2019 Jun. PMID: 31523307; PMCID: PMC6714362.
Copy Download .nbib Format: NLM
Impact of Low Volume Velocity-Controlled vs. Repetition to Failure Resistance Training Session on Measures of Explosive Performance in a Team of Adolescents Basketball Players.

Sports (Basel, Switzerland)

Kalmus OE, Viru M, Alvar B, Naclerio F.
PMID: 34437376
Sports (Basel). 2021 Aug 23;9(8). doi: 10.3390/sports9080115.

This study examined the short-term effects (post 6 h and 24 h) of two equated (70% of 1 repetition maximum (1-RM)) low volume resistance exercise protocols: (i) velocity-controlled (VC) and (ii) repetition to failure (RTF) on upper and lower...

Cite
Kalmus OE, Viru M, Alvar B, et al. Impact of Low Volume Velocity-Controlled vs. Repetition to Failure Resistance Training Session on Measures of Explosive Performance in a Team of Adolescents Basketball Players. Sports (Basel). 2021;9(8)doi: 10.3390/sports9080115.
Kalmus, O. E., Viru, M., Alvar, B., & Naclerio, F. (2021). Impact of Low Volume Velocity-Controlled vs. Repetition to Failure Resistance Training Session on Measures of Explosive Performance in a Team of Adolescents Basketball Players. Sports (Basel, Switzerland), 9(8), . https://doi.org/10.3390/sports9080115
Kalmus, Ott-Erik, et al. "Impact of Low Volume Velocity-Controlled vs. Repetition to Failure Resistance Training Session on Measures of Explosive Performance in a Team of Adolescents Basketball Players." Sports (Basel, Switzerland) vol. 9,8 (2021). doi: https://doi.org/10.3390/sports9080115
Kalmus OE, Viru M, Alvar B, Naclerio F. Impact of Low Volume Velocity-Controlled vs. Repetition to Failure Resistance Training Session on Measures of Explosive Performance in a Team of Adolescents Basketball Players. Sports (Basel). 2021 Aug 23;9(8). doi: 10.3390/sports9080115. PMID: 34437376; PMCID: PMC8402485.
Copy Download .nbib Format: NLM
Correction to: Effectiveness of combining microcurrent with resistance training in trained males.

European journal of applied physiology

Naclerio F, Seijo M, Karsten B, Brooker G, Carbone L, Thirkell J, Larumbe-Zabala E.
PMID: 31919581
Eur J Appl Physiol. 2020 Feb;120(2):549. doi: 10.1007/s00421-019-04294-4.

The original version of this article unfortunately contained a mistake.

Cite
Naclerio F, Seijo M, Karsten B, et al. Correction to: Effectiveness of combining microcurrent with resistance training in trained males. Eur J Appl Physiol. 2020;120(2):549doi: 10.1007/s00421-019-04294-4.
Naclerio, F., Seijo, M., Karsten, B., Brooker, G., Carbone, L., Thirkell, J., & Larumbe-Zabala, E. (2020). Correction to: Effectiveness of combining microcurrent with resistance training in trained males. European journal of applied physiology, 120(2), 549. https://doi.org/10.1007/s00421-019-04294-4
Naclerio, Fernando, et al. "Correction to: Effectiveness of combining microcurrent with resistance training in trained males." European journal of applied physiology vol. 120,2 (2020): 549. doi: https://doi.org/10.1007/s00421-019-04294-4
Naclerio F, Seijo M, Karsten B, Brooker G, Carbone L, Thirkell J, Larumbe-Zabala E. Correction to: Effectiveness of combining microcurrent with resistance training in trained males. Eur J Appl Physiol. 2020 Feb;120(2):549. doi: 10.1007/s00421-019-04294-4. PMID: 31919581; PMCID: PMC6989611.
Copy Download .nbib Format: NLM
The Effects of Functionally Guided, Connectivity-Based rTMS on Amygdala Activation.

Brain sciences

Beynel L, Campbell E, Naclerio M, Galla JT, Ghosal A, Michael AM, Kimbrel NA, Davis SW, Appelbaum LG.
PMID: 33924639
Brain Sci. 2021 Apr 13;11(4). doi: 10.3390/brainsci11040494.

While repetitive transcranial magnetic stimulation (rTMS) is widely used to treat psychiatric disorders, innovations are needed to improve its efficacy. An important limitation is that while psychiatric disorders are associated with fronto-limbic dysregulation, rTMS does not have sufficient depth...

Cite
Beynel L, Campbell E, Naclerio M, et al. The Effects of Functionally Guided, Connectivity-Based rTMS on Amygdala Activation. Brain Sci. 2021;11(4)doi: 10.3390/brainsci11040494.
Beynel, L., Campbell, E., Naclerio, M., Galla, J. T., Ghosal, A., Michael, A. M., Kimbrel, N. A., Davis, S. W., & Appelbaum, L. G. (2021). The Effects of Functionally Guided, Connectivity-Based rTMS on Amygdala Activation. Brain sciences, 11(4), . https://doi.org/10.3390/brainsci11040494
Beynel, Lysianne, et al. "The Effects of Functionally Guided, Connectivity-Based rTMS on Amygdala Activation." Brain sciences vol. 11,4 (2021). doi: https://doi.org/10.3390/brainsci11040494
Beynel L, Campbell E, Naclerio M, Galla JT, Ghosal A, Michael AM, Kimbrel NA, Davis SW, Appelbaum LG. The Effects of Functionally Guided, Connectivity-Based rTMS on Amygdala Activation. Brain Sci. 2021 Apr 13;11(4). doi: 10.3390/brainsci11040494. PMID: 33924639; PMCID: PMC8070235.
Copy Download .nbib Format: NLM
Understanding Substance use Policies and Associated Ethical Concerns: A survey of Pediatric Transplant Centers.

Pediatric transplantation

Monnin K, Lofton AM, Naclerio C, Buchanan CL, Campbell K, Tenenbaum RB, Steinberg Christofferson E.
PMID: 33580580
Pediatr Transplant. 2021 Jun;25(4):e13984. doi: 10.1111/petr.13984. Epub 2021 Feb 12.

Psychosocial risk factors, such as substance use, have been linked to poor post-transplant outcomes for solid organ transplant patients, including poor medication adherence, increased risk for rejection, and even graft failure. Despite universal consensus that substance use is an...

Cite
Monnin K, Lofton AM, Naclerio C, et al. Understanding Substance use Policies and Associated Ethical Concerns: A survey of Pediatric Transplant Centers. Pediatr Transplant. 2021;25(4):e13984doi: 10.1111/petr.13984.
Monnin, K., Lofton, A. M., Naclerio, C., Buchanan, C. L., Campbell, K., Tenenbaum, R. B., & Steinberg Christofferson, E. (2021). Understanding Substance use Policies and Associated Ethical Concerns: A survey of Pediatric Transplant Centers. Pediatric transplantation, 25(4), e13984. https://doi.org/10.1111/petr.13984
Monnin, Kara, et al. "Understanding Substance use Policies and Associated Ethical Concerns: A survey of Pediatric Transplant Centers." Pediatric transplantation vol. 25,4 (2021): e13984. doi: https://doi.org/10.1111/petr.13984
Monnin K, Lofton AM, Naclerio C, Buchanan CL, Campbell K, Tenenbaum RB, Steinberg Christofferson E. Understanding Substance use Policies and Associated Ethical Concerns: A survey of Pediatric Transplant Centers. Pediatr Transplant. 2021 Jun;25(4):e13984. doi: 10.1111/petr.13984. Epub 2021 Feb 12. PMID: 33580580.
Copy Download .nbib Format: NLM
ICON: chronic rhinosinusitis.

The World Allergy Organization journal

Bachert C, Pawankar R, Zhang L, Bunnag C, Fokkens WJ, Hamilos DL, Jirapongsananuruk O, Kern R, Meltzer EO, Mullol J, Naclerio R, Pilan R, Rhee CS, Suzaki H, Voegels R, Blaiss M.
PMID: 25379119
World Allergy Organ J. 2014 Oct 27;7(1):25. doi: 10.1186/1939-4551-7-25. eCollection 2014.

Chronic rhinosinusitis (CRS) is a public health problem that has a significant socio-economic impact. Moreover, the complexity of this disease due to its heterogeneous nature based on the underlying pathophysiology - leading to different disease variants - further complicates...

Cite
Bachert C, Pawankar R, Zhang L, et al. ICON: chronic rhinosinusitis. World Allergy Organ J. 2014;7(1):25doi: 10.1186/1939-4551-7-25.
Bachert, C., Pawankar, R., Zhang, L., Bunnag, C., Fokkens, W. J., Hamilos, D. L., Jirapongsananuruk, O., Kern, R., Meltzer, E. O., Mullol, J., Naclerio, R., Pilan, R., Rhee, C. S., Suzaki, H., Voegels, R., & Blaiss, M. (2014). ICON: chronic rhinosinusitis. The World Allergy Organization journal, 7(1), 25. https://doi.org/10.1186/1939-4551-7-25
Bachert, Claus, et al. "ICON: chronic rhinosinusitis." The World Allergy Organization journal vol. 7,1 (2014): 25. doi: https://doi.org/10.1186/1939-4551-7-25
Bachert C, Pawankar R, Zhang L, Bunnag C, Fokkens WJ, Hamilos DL, Jirapongsananuruk O, Kern R, Meltzer EO, Mullol J, Naclerio R, Pilan R, Rhee CS, Suzaki H, Voegels R, Blaiss M. ICON: chronic rhinosinusitis. World Allergy Organ J. 2014 Oct 27;7(1):25. doi: 10.1186/1939-4551-7-25. eCollection 2014. PMID: 25379119; PMCID: PMC4213581.
Copy Download .nbib Format: NLM
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.

Journal of autoimmunity

Ferri C, Ursini F, Gragnani L, Raimondo V, Giuggioli D, Foti R, Caminiti M, Olivo D, Cuomo G, Visentini M, Cacciapaglia F, Pellegrini R, Pigatto E, Urraro T, Naclerio C, Tavoni A, Puccetti L, Varcasia G, Cavazzana I, L'Andolina M, Ruscitti P, Vadacca M, Gigliotti P, La Gualana F, Cozzi F, Spinella A, Visalli E, Dal Bosco Y, Amato G, Masini F, Pagano Mariano G, Brittelli R, Aiello V, Caminiti R, Scorpiniti D, Rechichi G, Ferrari T, Monti M, Elia G, Franceschini F, Meliconi R, Casato M, Iannone F, Giacomelli R, Fallahi P, Santini SA, Zignego AL, Antonelli A.
PMID: 34781162
J Autoimmun. 2021 Dec;125:102744. doi: 10.1016/j.jaut.2021.102744. Epub 2021 Nov 10.

Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19 vaccines. Our prospective observational multicenter study aimed to evaluate the seroconversion after the vaccination cycle and at 6-12-month follow-up, as well the safety and efficacy of vaccines in preventing...

Cite
Ferri C, Ursini F, Gragnani L, et al. Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups. J Autoimmun. 2021;125:102744doi: 10.1016/j.jaut.2021.102744.
Ferri, C., Ursini, F., Gragnani, L., Raimondo, V., Giuggioli, D., Foti, R., Caminiti, M., Olivo, D., Cuomo, G., Visentini, M., Cacciapaglia, F., Pellegrini, R., Pigatto, E., Urraro, T., Naclerio, C., Tavoni, A., Puccetti, L., Varcasia, G., Cavazzana, I., L'Andolina, M., Ruscitti, P., Vadacca, M., Gigliotti, P., La Gualana, F., Cozzi, F., Spinella, A., Visalli, E., Dal Bosco, Y., Amato, G., Masini, F., Pagano Mariano, G., Brittelli, R., Aiello, V., Caminiti, R., Scorpiniti, D., Rechichi, G., Ferrari, T., Monti, M., Elia, G., Franceschini, F., Meliconi, R., Casato, M., Iannone, F., Giacomelli, R., Fallahi, P., Santini, S. A., Zignego, A. L., & Antonelli, A. (2021). Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups. Journal of autoimmunity, 125102744. https://doi.org/10.1016/j.jaut.2021.102744
Ferri, Clodoveo, et al. "Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups." Journal of autoimmunity vol. 125 (2021): 102744. doi: https://doi.org/10.1016/j.jaut.2021.102744
Ferri C, Ursini F, Gragnani L, Raimondo V, Giuggioli D, Foti R, Caminiti M, Olivo D, Cuomo G, Visentini M, Cacciapaglia F, Pellegrini R, Pigatto E, Urraro T, Naclerio C, Tavoni A, Puccetti L, Varcasia G, Cavazzana I, L'Andolina M, Ruscitti P, Vadacca M, Gigliotti P, La Gualana F, Cozzi F, Spinella A, Visalli E, Dal Bosco Y, Amato G, Masini F, Pagano Mariano G, Brittelli R, Aiello V, Caminiti R, Scorpiniti D, Rechichi G, Ferrari T, Monti M, Elia G, Franceschini F, Meliconi R, Casato M, Iannone F, Giacomelli R, Fallahi P, Santini SA, Zignego AL, Antonelli A. Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups. J Autoimmun. 2021 Dec;125:102744. doi: 10.1016/j.jaut.2021.102744. Epub 2021 Nov 10. PMID: 34781162; PMCID: PMC8577991.
Copy Download .nbib Format: NLM
Controlling subterranean forces enables a fast, steerable, burrowing soft robot.

Science robotics

Naclerio ND, Karsai A, Murray-Cooper M, Ozkan-Aydin Y, Aydin E, Goldman DI, Hawkes EW.
PMID: 34135117
Sci Robot. 2021 Jun 16;6(55). doi: 10.1126/scirobotics.abe2922.

Robotic navigation on land, through air, and in water is well researched; numerous robots have successfully demonstrated motion in these environments. However, one frontier for robotic locomotion remains largely unexplored-below ground. Subterranean navigation is simply hard to do, in...

Cite
Naclerio ND, Karsai A, Murray-Cooper M, et al. Controlling subterranean forces enables a fast, steerable, burrowing soft robot. Sci Robot. 2021;6(55)doi: 10.1126/scirobotics.abe2922.
Naclerio, N. D., Karsai, A., Murray-Cooper, M., Ozkan-Aydin, Y., Aydin, E., Goldman, D. I., & Hawkes, E. W. (2021). Controlling subterranean forces enables a fast, steerable, burrowing soft robot. Science robotics, 6(55), . https://doi.org/10.1126/scirobotics.abe2922
Naclerio, Nicholas D, et al. "Controlling subterranean forces enables a fast, steerable, burrowing soft robot." Science robotics vol. 6,55 (2021). doi: https://doi.org/10.1126/scirobotics.abe2922
Naclerio ND, Karsai A, Murray-Cooper M, Ozkan-Aydin Y, Aydin E, Goldman DI, Hawkes EW. Controlling subterranean forces enables a fast, steerable, burrowing soft robot. Sci Robot. 2021 Jun 16;6(55). doi: 10.1126/scirobotics.abe2922. PMID: 34135117.
Copy Download .nbib Format: NLM
Heterogeneity of the white truffle Tuber magnatum in a limited geographic area of Central-Southern Italy.

Environmental microbiology reports

Monaco P, Bucci A, Naclerio G, Mello A.
PMID: 33943006
Environ Microbiol Rep. 2021 Oct;13(5):591-599. doi: 10.1111/1758-2229.12956. Epub 2021 May 04.

Molise region (Central-Southern Italy) is one of the Italian richest areas of truffles and contributes significantly to the national production of the precious Tuber magnatum. Nevertheless, Molise truffle has received little scientific attention. Accordingly, in the present study, two...

Cite
Monaco P, Bucci A, Naclerio G, et al. Heterogeneity of the white truffle Tuber magnatum in a limited geographic area of Central-Southern Italy. Environ Microbiol Rep. 2021;13(5):591-599doi: 10.1111/1758-2229.12956.
Monaco, P., Bucci, A., Naclerio, G., & Mello, A. (2021). Heterogeneity of the white truffle Tuber magnatum in a limited geographic area of Central-Southern Italy. Environmental microbiology reports, 13(5), 591-599. https://doi.org/10.1111/1758-2229.12956
Monaco, Pamela, et al. "Heterogeneity of the white truffle Tuber magnatum in a limited geographic area of Central-Southern Italy." Environmental microbiology reports vol. 13,5 (2021): 591-599. doi: https://doi.org/10.1111/1758-2229.12956
Monaco P, Bucci A, Naclerio G, Mello A. Heterogeneity of the white truffle Tuber magnatum in a limited geographic area of Central-Southern Italy. Environ Microbiol Rep. 2021 Oct;13(5):591-599. doi: 10.1111/1758-2229.12956. Epub 2021 May 04. PMID: 33943006.
Copy Download .nbib Format: NLM
Indications for pulmonary resection, special reference to extent of operation.

American journal of surgery

NACLERIO EA.
PMID: 18108592
Am J Surg. 1949 Feb;77(2):140-51. doi: 10.1016/0002-9610(49)90416-x.

No abstract available.

Cite
NACLERIO EA. Indications for pulmonary resection, special reference to extent of operation. Am J Surg. 1949;77(2):140-51doi: 10.1016/0002-9610(49)90416-x.
NACLERIO, E. A. (1949). Indications for pulmonary resection, special reference to extent of operation. American journal of surgery, 77(2), 140-51. https://doi.org/10.1016/0002-9610(49)90416-x
NACLERIO, E A. "Indications for pulmonary resection, special reference to extent of operation." American journal of surgery vol. 77,2 (1949): 140-51. doi: https://doi.org/10.1016/0002-9610(49)90416-x
NACLERIO EA. Indications for pulmonary resection, special reference to extent of operation. Am J Surg. 1949 Feb;77(2):140-51. doi: 10.1016/0002-9610(49)90416-x. PMID: 18108592.
Copy Download .nbib Format: NLM
Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative.

ClinicoEconomics and outcomes research : CEOR

Colombo GL, Di Matteo S, Martinotti C, Jugl SM, Gunda P, Naclerio M, Bruno GM.
PMID: 30214261
Clinicoecon Outcomes Res. 2018 Aug 30;10:477-491. doi: 10.2147/CEOR.S171560. eCollection 2018.

OBJECTIVE: Secukinumab, a fully human monoclonal IgG1 antibody that selectively neutralizes the proinflammatory cytokine IL-17A, has been approved in Europe in 2015 for the treatment of adult patients with moderate-to-severe plaque psoriasis, psoriatic arthritis (PsA), and ankylosing spondylitis (AS)....

Cite
Colombo GL, Di Matteo S, Martinotti C, et al. Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative. Clinicoecon Outcomes Res. 2018;10:477-491doi: 10.2147/CEOR.S171560.
Colombo, G. L., Di Matteo, S., Martinotti, C., Jugl, S. M., Gunda, P., Naclerio, M., & Bruno, G. M. (2018). Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative. ClinicoEconomics and outcomes research : CEOR, 10477-491. https://doi.org/10.2147/CEOR.S171560
Colombo, Giorgio L, et al. "Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative." ClinicoEconomics and outcomes research : CEOR vol. 10 (2018): 477-491. doi: https://doi.org/10.2147/CEOR.S171560
Colombo GL, Di Matteo S, Martinotti C, Jugl SM, Gunda P, Naclerio M, Bruno GM. Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative. Clinicoecon Outcomes Res. 2018 Aug 30;10:477-491. doi: 10.2147/CEOR.S171560. eCollection 2018. PMID: 30214261; PMCID: PMC6121773.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 48 entries